Understanding Your Immunotherapy Consent Form — What You Are Actually Signing

What Are You Agreeing To When You Sign an Immunotherapy Consent Form?

You are recording that a specific immunotherapy plan was explained to you, that you understood its purpose, its risks and its alternatives, and that you agree to start it. You are not signing away your right to safe care, to ask questions later, or to stop treatment. Consent is permission for a plan, not a waiver.

The form usually arrives at the worst possible moment. The appointment has run long, there is a queue outside, and someone points at a line and says “sign here”. Families later tell us they signed without reading because they assumed it was paperwork, or because they were afraid that asking questions would delay treatment or annoy the doctor.

It is neither. Indian medical ethics guidance treats informed consent as an ongoing conversation, not a single signature. The document simply records that the conversation happened. Which means that if the conversation did not happen, the form is not doing its job — and you are entitled to say so before you sign it.

Most immunotherapy consent forms in India follow the same shape. Here is what each part is actually saying, and the one thing worth checking in each.

Form wording differs between hospitals, so treat the table above as a guide to the shape of the document rather than a line-by-line match. What should not differ is your right to have every section explained before you sign it.

What Risks Are Listed on an Immunotherapy Consent Form?

The form lists immune-related adverse events organ by organ — gut, lungs, liver, thyroid and other hormone glands, skin, joints, kidneys and, less commonly, the heart and nervous system — plus infusion reactions. It will say these can be severe, can need steroids or admission, and can begin months after the last dose.

That list frightens people, and it reads as though everything on it is likely. It is not. Immunotherapy works by taking brakes off the immune system, so the form has to name every organ that inflammation could reach. Most patients experience none of the severe events on the page, some experience one, and a proportion experience more than one.

There is a more useful way to read it. Every item on that list is something the centre treating you should be able to recognise early and treat quickly — on a Sunday night as readily as on a Tuesday morning. So read the risk list as a capability question and ask it out loud: who here manages this, and how fast can I be seen?

The timing bands above describe the general pattern set out in NCCN, ASCO and ESMO guidance on immune-related adverse events. Individual cases vary widely, and any of these can appear earlier or much later than the typical window.

Diarrhoea, breathlessness, chest pain, severe fatigue or dizziness during or after immunotherapy is a call-now situation, not something to treat at home or wait out until the next appointment. Call your treating centre immediately, or reach CION on 1800 202 8726, and go to the nearest emergency department if the symptom is severe.

Can You Ask for Changes to the Consent Form?

Yes. You can ask for anything you do not understand to be rewritten in plain words, ask for the form in Telugu or Hindi, strike out optional permissions such as photography or research use, and take it home overnight unless treatment is genuinely urgent. A change you initial and date is valid.

Almost nobody does this, because the form looks fixed and printed and official. Parts of it are. The clinical plan is not something you edit. But the optional permissions, the blanks, the language and the timing are all yours to question, and no reasonable team treats that as difficult.

If a request to read the form overnight is met with irritation rather than an explanation of why the timing matters, that response is itself information about the centre.

What Should the Consent Conversation Cover Before You Sign?

Six things, and none of them are on the form. Who manages an immune side effect here. What number you dial at 2 a.m. Where your scans are actually done. What the centre refers out. What one cycle is likely to cost, itemised. And what happens if you say no, or want a second opinion first.

The signature is the last step of the decision, not the decision itself. These are the questions that should be answered before the pen appears, and they are the same questions worth asking of any centre you are considering.

• “Who manages an immune-related side effect here, and how fast can I be seen?” Listen for a named oncologist, a written protocol for grading and treating these events, and same-day review when something starts. Our page on questions to ask a centre before starting immunotherapy sets out what a solid answer sounds like.
• “What number do I call outside clinic hours, and who picks it up?” Ask for it written on your treatment card, and ask whether whoever answers can see your file. If you live two hours away, ask which nearby hospital could admit you tonight. Travel times quoted to you are indicative and change with traffic and time of day.
• “Is my response scan done here or somewhere else?” At CION, immunotherapy is administered as day care at our centres, and response-assessment PET-CT is coordinated at partner imaging centres rather than owned by us. Ask any centre to be equally specific about where you physically go and who books it.
• “What does this centre refer out rather than do itself?” CION does not provide CAR-T or cell therapy. Those are delivered by a small number of specialised centres in India, and we refer onward rather than administer or stock them. A centre that names its limits is easier to trust on everything else.
• “What is one cycle likely to cost, itemised, and what is excluded?” Drug, day-care charge, consultation, pre-cycle blood tests and pharmacy handling as separate lines; scans, biomarker testing and admission usually excluded. Every figure is indicative, as of August 2026.
• “What happens if I say no today, or want a second opinion first?” The answer should be an unhesitating offer to release your reports and slides. If you are still weighing where to be treated, how to choose a centre for immunotherapy works through the criteria that actually matter.

Write the answers down during the appointment. A consent form signed after these six answers is a decision. One signed before them is just a signature.

Who Signs the Consent Form If the Patient Cannot?

An adult who can understand and decide signs for themselves, even when the family would rather they did not. For a child, a parent or legal guardian signs. If the patient genuinely cannot understand or communicate, hospital policy decides who may consent on their behalf — usually the closest available relative. Ask the centre what its policy is.

This is where Indian families and hospital paperwork most often pull in opposite directions. It is common here for an adult child to want to sign on a parent’s behalf, or for a diagnosis to be softened so the patient never hears the full picture. The form assumes the opposite: that the person receiving the treatment is the person deciding on it.

Three practical points are worth settling before the appointment rather than at the counter.

• A relative’s signature does not replace the patient’s. While the patient can understand the explanation and express a decision, the signature is theirs. A relative may sign as witness, or in addition, but not instead.
• There is usually more than one form. The immunotherapy consent is often separate from consent for a port or central line, for blood products, or for a biopsy. Ask how many you are signing and what each one covers.
• The witness line matters. The witness is confirming that the explanation was given and understood, in a language the patient reads. If the explanation happened in Telugu and the form is in English, ask for that to be recorded.

If the patient is too unwell to take part, ask the centre directly which relative its policy recognises, what documents that relative needs to carry, and whether anything can wait until the patient is able to decide. Where the family is divided, say so early — it is far easier to resolve before treatment starts than in the middle of a cycle.

What Else Should You Settle Before Treatment Starts?

Three questions usually follow this one: how to choose between the centres in front of you, what to ask each of them, and whether the nearer, smaller option is a safe one.

Ask Us to Explain the Form First

Consent should be the end of a conversation, not the start of one. We will walk you through every section before you decide.